rawfin.tv
United Therapeutics CEO Sells $5.1 Million in UTHR Stock
MarketsstocksAI Generated

United Therapeutics CEO Sells $5.1 Million in UTHR Stock

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Martine Rothblatt, CEO of United Therapeutics Corp, has sold approximately $5.1 million worth of her company's stock. This insider transaction reflects a significant divestment by a key executive.

United TherapeuticsInsider SellingBiotechnologyExecutive Transactions

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks